文献速递乳腺MR

基于深度学习的乳腺MRI BI-RADS预测模型开发与外部验证

Development and external validation of a deep learning-based BI-RADS prediction model for breast MRI.
PubMed 文献 · Eur J Radiol · 2026-09-23

本研究回顾性纳入三个机构2012至2024年12421例乳腺MRI,开发深度学习模型预测BI-RADS分类,并在独立门诊影像中心158例外部验证队列中评估恶性诊断效能。结果显示,模型AUC为0.767,低于放射科医师的0.913,差异有统计学意义。

要点

  • 该AI模型BI-RADS大于3为标准时,可将54.7%的良性检查判为低风险,NPV为97.4%。
  • 模型总体区分恶性能力低于常规放射科医师评估,尚不能直接替代人工阅片。
  • 能否利用该模型安全改善工作流程,仍需前瞻性评价。

核心结论

  • 深度学习模型区分恶性病变的AUC低于常规放射科医师评估,差异为0.146,具有统计学意义。
  • 在该评估阈值下模型仍保持较高敏感度,但其识别低风险检查能否安全改善流程需要前瞻性评估。

研究设计与样本

  • 回顾性多中心研究,开发队列纳入2012至2024年三家机构12421例乳腺MRI检查。
  • 训练数据来自1.5T和3T MRI系统,采用动态增强扫描方案,以放射科医师赋予的BI-RADS类别作为训练监督目标。
  • 外部验证采用独立回顾性队列,包含某门诊影像中心6个月内158例乳腺MRI,使用不同硬件与扫描方案。
  • 诊断恶性效能采用ROC分析,并以DeLong检验与专家放射科医师评估进行比较。
  • 外部验证队列中恶性21例,良性137例。

诊断标准与关键数值

  • 放射科医师评估的AUC为0.913,95%置信区间0.857–0.952。
  • AI模型的AUC为0.767,95%置信区间0.693–0.830。
  • 以BI-RADS大于3为阈值时,AI模型将全部良性检查的54.7%判定为低风险,阴性预测值为97.4%。

临床应用与阅片要点

  • 该AI模型在预设阈值下可识别约半数以上良性检查为低风险,具有潜在分流价值。
  • 日常报告不能以该模型输出直接替代放射科医师对乳腺MRI的BI-RADS分类。
  • 临床应用需注意模型与医师评估之间存在显著诊断效能差距,需谨慎解读低风险判定。

局限性

  • 该研究标签基于放射科医师赋予的BI-RADS类别而非纯病理金标准。
  • 外部验证队列来自门诊影像中心,MRI硬件与扫描方案与训练数据不同。
  • 研究为回顾性设计,模型用于识别低风险检查的安全性仍需前瞻性研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Breast MRI is the most sensitive imaging modality for breast cancer detection but requires time-intensive interpretation by experienced breast radiologists. Artificial intelligence (AI) has emerged as a promising tool to support image interpretation; however, robust external validation across heterogeneous clinical settings remains limited.

PURPOSE: To develop a deep learning-based model for automated BI-RADS prediction from breast MRI and to externally evaluate its diagnostic performance on an independent dataset using a clinical reference standard for malignancy.

MATERIALS AND METHODS: In this retrospective multicenter study, a deep learning model was developed using 12,421 breast MRI examinations acquired between 2012 and 2024 at three institutions. The model was trained using radiologist-assigned BI-RADS categories as supervision targets and externally evaluated against a clinical reference standard for malignancy. Training data included examinations performed on 1.5-T and 3-T MRI systems using dynamic contrast-enhanced protocols. External validation was performed using an independent retrospective cohort of 158 breast MRI examinations acquired at an outpatient imaging center over a six-month period using different MRI hardware and imaging protocols. Diagnostic performance for malignancy was assessed using receiver operating characteristic (ROC) analysis and compared with expert radiologist assessment using the DeLong test.

RESULTS: The external validation cohort consisted of 158 examinations, including 21 malignant and 137 benign cases. Radiologist assessment achieved an area under the ROC curve (AUC) of 0.913 (95 % confidence interval [CI]: 0.857-0.952), whereas the AI model achieved an AUC of 0.767 (95 % CI: 0.693-0.830), corresponding to a statistically significant difference of 0.146 (P = 0.0001). At a BI-RADS threshold greater than 3, the AI model identified 54.7 % of all benign examinations as low-risk at a negative predictive value (NPV) of 97.4 %.

CONCLUSION: The deep learning model showed lower discrimination than routine radiologist assessment but maintained high sensitivity at the evaluated threshold. Whether its identification of low-risk examinations can safely improve workflow requires prospective evaluation.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Brader, Spick, Szolar, et al. Development and external validation of a deep learning-based BI-RADS prediction model for breast MRI. Eur J Radiol. 2026. PMID: 42804814. doi:10.1016/j.ejrad.2026.113267

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。